Heath Lukatch, Director at Vaxcyte, Inc. (PCVX), sold 4,335 shares at $46.25 ($200K) on 2022-11-10, disclosed to the SEC on 2022-11-15.
Open-market sale of $200k PCVX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.74 | 335 | $15K | 7.5% |
| 2 | $46.25 | 4,000 | $185K | 92.5% |
| Total | $46.13 avg | 4,335 | $200K | 100% |
| Filing → |
| PCVX | SELL | 2024-01-04 | $1.6M | — | Filing → |
| PCVX | SELL | 2023-01-12 | $15K | — | Filing → |
| PCVX | SELL | 2022-12-14 | $15K | — | Filing → |